Table 3 |
||||||
|
Risk factors associated with acute organ failure. |
||||||
|
Predictor variable |
Univariate analysis |
Multivariate analysis (n = 108) |
||||
|
OR1 |
95% CI |
P-value |
OR1 |
95% CI1 |
P-value2, 3 |
|
|
|
||||||
|
Age (years) |
1.00 |
0.99 - 1.03 |
0.339 |
0.381 |
||
|
APACHE II |
1.09 |
1.02 - 1.17 (n = 120) |
0.008 |
1.08 |
1.00 - 1.17 |
0.064 |
|
Female gender |
1.02 |
0.47 - 2.23 |
0.960 |
0.668 |
||
|
OPR/Theatre admission |
0.44 |
0.20 - 1.01 |
0.052 |
0.324 |
||
|
Admission PaO2/FiO2 ratio |
0.80 |
0.58 - 1.00 (n = 114) |
0.038 |
0.498 |
||
|
Hypoxemic failure |
4.56 |
1.98 - 10.53 (n = 120) |
< 0.001 |
5.63 |
1.95 - 16.26 |
0.001 |
|
Type 2 (ventilatory) failure |
0.11 |
0.01 - 0.86 (n= 120) |
0.035 |
0.208 |
||
|
Positive end-expiratory pressure support (PEEP) only |
0.14 |
0.02 - 1.12 (n = 116) |
0.064 |
0.411 |
||
|
PEEP and positive pressure inspiratory support |
8.95 |
1.12 - 71.42 (n = 116) |
0.039 |
7.00 |
0.61 - 79.79 |
0.117 |
|
Endotracheal tube |
2.76 |
1.16 - 6.59 (n = 116) |
0.022 |
0.353 |
||
|
Previous statin therapy |
1.10 |
0.98 - 1.24 |
0.112 |
1.16 |
0.99 - 1.35 |
0.064 |
|
Statin on ICU day 1 |
0.35 |
0.09 - 1.32 (n = 116) |
0.122 |
0.18 |
0.03- 1.13 |
0.068 |
|
Admitted with an infection |
2.42 |
1.02 - 5.73 |
0.044 |
0.985 |
||
|
Admission lactate |
1.06 |
0.86 - 1.32 (n = 110) |
0.579 |
0.209 |
||
|
Admission white cell count |
1.00 |
0.93 - 1.06 (n = 115) |
0.880 |
0.570 |
||
|
Cardiovascular dysfunction |
2.80 |
1.55 - 5.05 |
0.001 |
2.06 |
1.02 - 4.14 |
0.044 |
|
Renal dysfunction |
2.21 |
1.10 - 4.45 |
0.026 |
2.32 |
0.93 - 5.79 |
0.070 |
|
Hepatic dysfunction |
2.67 |
1.11 - 6.39 |
0.028 |
0.248 |
||
|
Haematological dysfunction |
1.86 |
0.87 - 3.99 |
0.111 |
0.714 |
||
|
|
||||||
|
1OR (odds ratio) per one unit change, as appropriate for each variable. 2Value adjusted for other variables when OR and 95% CI (confidence interval) presented. 3Likelihood ratio value for variable selection when OR and 95% CI not presented. APACHE, acute physiology and chronic health evaluation; ICU, intensive care unit; OPR, operating room; PaO2/FiO2, |
||||||
|
Terblanche et al. Critical Care 2012 16:R61 doi:10.1186/cc11306 |
||||||